Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer

Published:2024-05 Issue: Volume:191 Page:107540
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tozuka Takehiro^ORCID,Noro Rintaro^ORCID,Mizutani Hideaki,Kurimoto Futoshi,Hakozaki Taiki^ORCID,Hisakane Kakeru,Naito Tomoyuki,Takahashi Satoshi^ORCID,Taniuchi Namiko^ORCID,Yajima Chika,Hosomi Yukio^ORCID,Hirose Takashi,Minegishi Yuji,Okano Tetsuya^ORCID,Kamio Koichiro^ORCID,Yamaguchi Tomoyoshi,Seike Masahiro^ORCID

Publisher

Elsevier BV

Reference45 articles.

1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008

2. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system;Barnholtz-Sloan;J. Clin. Oncol.,1973

3. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma;Saad;Cancer.,2008

4. Brain metastases. Histology, Multiplicity, Surgery, and Survival;Nussbaum;Cancer,1996

5. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer;Peters;Cancer Treat. Rev.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC;ESMO Real World Data and Digital Oncology;2024-09

2. Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis;Cancers;2024-04-29